Keiichiro Imanaka

487 total citations
16 papers, 352 citations indexed

About

Keiichiro Imanaka is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cancer Research. According to data from OpenAlex, Keiichiro Imanaka has authored 16 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 4 papers in Cancer Research. Recurrent topics in Keiichiro Imanaka's work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Keiichiro Imanaka is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Keiichiro Imanaka collaborates with scholars based in Japan, Belgium and United States. Keiichiro Imanaka's co-authors include Mila Etropolski, Y. Tokura, B. Randazzo, Yoko Murata, Ryo Tamamura, Kenji Kabashima, Ai Shiraishi, Hidehisa Saeki, Hiroji Uemura and Hirotsugu Uemura and has published in prestigious journals such as British Journal of Dermatology, Current Medical Research and Opinion and Japanese Journal of Clinical Oncology.

In The Last Decade

Keiichiro Imanaka

16 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiichiro Imanaka Japan 10 124 95 91 78 71 16 352
J Hidding Netherlands 6 20 0.2× 17 0.2× 53 0.6× 16 0.2× 4 0.1× 10 410
Robert J. Albin United States 7 149 1.2× 4 0.0× 37 0.4× 7 0.1× 11 0.2× 11 356
Satoru Sakagami Japan 11 35 0.3× 6 0.1× 26 0.3× 6 0.1× 11 0.2× 29 433
O. Laccourreye France 12 107 0.9× 4 0.0× 80 0.9× 19 0.2× 9 0.1× 56 492
Jeen Liu United States 8 283 2.3× 22 0.2× 415 4.6× 2 0.0× 274 3.9× 10 572
Lisa Lohr United States 5 61 0.5× 5 0.1× 41 0.5× 5 0.1× 4 0.1× 12 316
T.C. Stokes United Kingdom 11 211 1.7× 2 0.0× 138 1.5× 7 0.1× 22 0.3× 18 293
Michel van der Jagt Netherlands 11 81 0.7× 3 0.0× 11 0.1× 65 0.8× 13 0.2× 18 299
Sue Southworth United Kingdom 10 25 0.2× 22 0.2× 23 0.3× 15 0.2× 15 496
Marie-Noëlle Robitaille United States 6 268 2.2× 13 0.1× 263 2.9× 1 0.0× 47 0.7× 8 374

Countries citing papers authored by Keiichiro Imanaka

Since Specialization
Citations

This map shows the geographic impact of Keiichiro Imanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichiro Imanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichiro Imanaka more than expected).

Fields of papers citing papers by Keiichiro Imanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichiro Imanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichiro Imanaka. The network helps show where Keiichiro Imanaka may publish in the future.

Co-authorship network of co-authors of Keiichiro Imanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichiro Imanaka. A scholar is included among the top collaborators of Keiichiro Imanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichiro Imanaka. Keiichiro Imanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
3.
4.
5.
Tsuchiya, Tomohiro, Keiichiro Imanaka, Yuki Iwaki, et al.. (2019). An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer. International Journal of Clinical Oncology. 24(12). 1596–1604. 8 indexed citations
6.
Nakayama, Masahiko, et al.. (2018). Patient Preferences and Urologist Judgments on Prostate Cancer Therapy in Japan. American Journal of Men s Health. 12(4). 1094–1101. 13 indexed citations
7.
Mahlich, Jörg, et al.. (2018). Burden of illness of chemotherapy in castration-resistant prostate cancer patients in Japan: a retrospective database analysis. Current Medical Research and Opinion. 34(10). 1855–1860. 6 indexed citations
8.
Saeki, Hidehisa, Kenji Kabashima, Y. Tokura, et al.. (2017). Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study. British Journal of Dermatology. 177(2). 419–427. 92 indexed citations
9.
10.
Arai, Tsutomu, et al.. (2015). Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-naïve patients with chronic pain. Current Medical Research and Opinion. 31(12). 2207–2218. 17 indexed citations
11.
Matsubara, Nobuaki, Hirotsugu Uemura, Takefumi Satoh, et al.. (2014). A Phase 2 Trial of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer and without Prior Chemotherapy (JPN-201 Study). Japanese Journal of Clinical Oncology. 44(12). 1216–1226. 29 indexed citations
12.
Satoh, Toshihiko, Hiroji Uemura, K. Tanabe, et al.. (2014). A Phase 2 Study of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer Who Had Received Docetaxel-based Chemotherapy. Japanese Journal of Clinical Oncology. 44(12). 1206–1215. 24 indexed citations
13.
Imanaka, Keiichiro, et al.. (2014). Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release. Clinical Drug Investigation. 34(7). 501–511. 36 indexed citations
14.
Imanaka, Keiichiro, et al.. (2013). Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain. Current Medical Research and Opinion. 29(10). 1399–1409. 56 indexed citations
15.
Masuda, Fujio, et al.. (1994). CONSERVATIVE SURGERY FOR RENAL CELL CARCINOMA. The Japanese Journal of Urology. 85(3). 446–451. 1 indexed citations
16.
Kondo, Naoya, et al.. (1987). VP-16 SALVAGE THERAPY FOR PVB REGIMEN-RESISTANT TESTICULAR GERM CELL TUMORS. The Japanese Journal of Urology. 78(7). 1227–1231. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Hidding Breakdown of academic impact, for papers by Robert J. Albin Breakdown of academic impact, for papers by Satoru Sakagami Breakdown of academic impact, for papers by O. Laccourreye Breakdown of academic impact, for papers by Jeen Liu Breakdown of academic impact, for papers by Lisa Lohr Breakdown of academic impact, for papers by T.C. Stokes Breakdown of academic impact, for papers by Michel van der Jagt Breakdown of academic impact, for papers by Sue Southworth Breakdown of academic impact, for papers by Marie-Noëlle Robitaille
Rankless by CCL
2026